Drug General Information
Drug ID	D0J3NJ
Former ID	DIB010323
Drug Name	RP-69698
Drug Type	Small molecular drug
Indication	Inflammatory disease [ICD9: 140-229, 147, 173, 573.3, 710-719; ICD10:C11, C44, K75.9, M00-M25]		Terminated	[545550]
Company	Rhone-Poulenc SA
Structure		Download 2D MOL 3D MOL
Formula	C23H23N5O
Canonical SMILES	n1n[nH]c(n1)C(CCCCOc1nc(cc(c1)c1ccccc1)c1ccccc1)(C)C
CAS Number	CAS 141748-00-7
PubChem Compound ID	10452674
Target and Pathway
Target(s)	Leukotriene B4 receptor 1	Target Info	Modulator	[526761]
KEGG Pathway	Neuroactive ligand-receptor interaction
NetPath Pathway	IL4 Signaling Pathway
Reactome	Leukotriene receptors
	G alpha (q) signalling events
WikiPathways	Nucleotide GPCRs
	GPCRs, Class A Rhodopsin-like
	Gastrin-CREB signalling pathway via PKC and MAPK
	Spinal Cord Injury
	GPCR ligand binding
	GPCR downstream signaling
References
Ref 545550	Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800003683)
Ref 526761	omega-[(4,6-Diphenyl-2-pyridyl)oxy]alkanoic acid derivatives: a new family of potent and orally active LTB4 antagonists. J Med Chem. 1992 Nov 13;35(23):4315-24.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.